logo
Inaugural Research Day Even

Dhahran, December 4 - Johns Hopkins Aramco Healthcare (JHAH) Inaugural Research Day Event Brings International Experts Together in the Exploration of Enhancing Quality of Care and Treatment.

The day, which included a symposium and research poster exhibition, was inaugurated by Yasser Mufti, Vice President, Strategy & Market Analysis, Saudi Aramco, and member of the JHAH Board of Managers. “The parent organizations of JHAH are no strangers to innovation and research. JHAH, through its predecessor SAMSO, has a long history of innovation. Since the joint venture was launched, we have embarked on significant investments that will further enable research, the foremost being Epic. Finally, and perhaps most importantly, we have top talent throughout JHAH. Thus, all the ingredients are coming into place. We have the right heritage, right equipment and right people. The JHAH Research Day marks an important milestone in the JHAH journey of research and innovation.” Stated Yasser Mufti.

Other leading figures from the research community also participated, including key note speaker, Daniel Ford, MD, MPH, Professor of Medicine and Director Johns Hopkins Institute for Clinical and Translational Research; Dr. Edgar Miller III, MD, Ph.D., Deputy Director, Johns Hopkins Institute for Clinical and Translational Research; Abdulmohsen Al Majnouni, CEO, Research Products Development Company; Dr. Abdulaziz Mohammed Al-Swailem, Vice President for Research Support, King Abdulaziz City for Science and Technology (KACST), and Professor Pierre Magistretti, Dean Bioscience, Biological and Environmental Science and Engineering, KAUST.

Commenting on the event, Abdulmohsen Al-Majnouni said, “As head of the Research Products Development Company, what I heard today is music to my ears. Until now I knew about JHAH but was not familiar with its research activities. Moving ahead, I look forward to collaborating with researchers here to commercialize discoveries or inventions so people can benefit.”

Dr. Al-Swailem stated, “The JHAH Research Day provides an excellent opportunity for us at KACST to learn more about the medical research interests and capabilities at JHAH so going forward we can explore ways to align our resources to achieve our shared goals and have a positive impact on the health of people in the Kingdom, region and ultimately the world as well as contribute to the Kingdom meeting its 2030 vision.”

When Saudi Aramco and Johns Hopkins Medicine International formed Johns Hopkins Aramco Healthcare (JHAH), the two quickly aligned to develop clinical research capabilities and help propel the Kingdom's ongoing drive for international competitiveness in biomedical research and technology. The work began by enhancing what had previously been an informal research office, this involved clearly defining the needed infrastructure, establishing research-ready databases and making the environment even more encouraging for research possibilities. An official research office has been established to elevate how medical research is viewed, performed and applied at JHAH. This a part of the Office of Academic Affairs, headed by Dr. Abdulrazack Amir. The JHAH Institutional Review Board (IRB) is accredited by the National Committee of Bioethics and was recognized as one of the top three IRBs in the Kingdom in 2017. Its role is ethical oversight and approval of human subject research.

“Research at JHAH focuses on projects to improve the efficiency and quality of patient care. Discoveries have included the longest surviving reported case of Lupus in literature and this will contribute to a better understanding and treatment of the disease. By conducting unique studies that are directly linked to the disease burden of the local population, JHAH is ideally positioned to advance the knowledge and therapeutic care for our patients.” Dr. Daniele Rigamonti, CEO, JHAH.

The medical joint venture partner, Johns Hopkins, has a rich history of world-changing discoveries, remarkably 21 current/former Johns Hopkins scientists are Nobel Prize laureates. Discoveries made at Johns Hopkins include: making water purification possible; launching the field of genetic engineering; inventing saccharine, Mercurochrome, and rubber surgical gloves; and developing a revolutionary surgical procedure to correct heart defects in infants.


Research Day Winners

Posters

Ranking Primary Investigator Title of Poster Category
1 Dr. Iyad Eid A Quality Iimprovement Project Decreases Incidence of Pulmonary Embolism Following Arthroplasty Allied Health
2 Ms. Huda Alsayed Molecular and Immunological Analysis of the Effect of Tumor Associated Macrophages on Prognosis of Hodgkin’s Lymphoma in Saudi Patients Allied Health
3 Ms. Amani Babgi Analysis of Do Not Resuscitate Order (DNR) & Allow Natural Death (AND) Practice in Saudi Arabia: Experience of Three Major Centers Allied Health
1 Dr. Baraa Amir Comparative Analysis of Community Acquired Methicillin Resistant Staphylococcus Aureus Nasal Carriage in Eastern Provence of Saudi Arabia Resident
2 Dr. Motazz Alarfaj White Dot Syndrome: A Rare Case of Acute Posterior Multifocal Placoid Pigment Epitheliopathy Associated With a Prodromal Viral Upper Respiratory Tract Infection Resident
3 Dr. Jumana Amir Renal Limited Lupus-Like Nephritis - A Case Report and Review of Literature Resident
1 Dr. Najla AlDawsari Knowledge and Practice of Recreational Tanning Among Female College Students in the Eastern Province of Saudi Arabia.
A Cross Sectional Study
Consultant
2 Dr. Nouriya AlSannaa The Clinical and Genetic Spectrum of Maroteaux-Lamy Syndrome (Mucopolysaccharidosis VI) in the Eastern Province of Saudi Arabia Consultant
3 Dr. Eric McWilliams Left Sided Mc Connells Sign: A Classic Finding in a Rare Condition Consultant
1 Ms. Kawthar Hussain Improving Transition of Care from an Inpatient to Outpatient Setting for Adult Patients with Sickle Cell Disease at Johns Hopkins Aramco Healthcare DNP
2 Siobhan Rothwell Compliance within 10 Minutes for Suspected ST Elevation Myocardial Infarction (STEMI) – A Quality Initiative DNP
3 Ms. Maisa Rabaan Evidence Based strategies to Reduce Central Line Associated Blood Stream Infection in the Intensive Care Unit at Johns Hopkins Aramco Healthcare DNP

Presentations

Ranking Presenter Title of Presentation
1 Ms. Vidagay Baky Obtaining a follow-up appointment before discharge protects against readmission for patients with acute coronary syndrome and heart failure: A quality improvement project
2 Dr. Rawan Amir Pancreatic Metastasis From Malignant Phyllodes Tumor of the Breast: A Case Report and Review of Literature
3 Dr. MojiebHaque Manzary Global intra operative anthropometry study of distal femoral aspect ratio of multiple ethnicities in short statured females with Tricompartmental Osteoarthritis
4 Dr. Eric McWilliams Taku tsubo cardiomyopathy: A clinical case series in Saudi Arabia